Abstract
Diabetes mellitus (DM) is the major cause of end-stage renal disease (ESRD) globally, and novel treatments are urgently needed. Current therapeutic approaches for diabetic nephropathy (DN) are focussing on blood pressure control with inhibitors of the renin–angiotensin–aldosterone system, on glycaemic and lipid control, and life-style changes. In this review, we highlight new molecular insights aiding our understanding of the initiation and progression of DN, including glomerular insulin resistance, dysregulation of cellular substrate utilisation, podocyte–endothelial communication, and inhibition of tubular sodium coupled glucose reabsorption. We believe that these mechanisms offer new therapeutic targets that can be exploited to develop important renoprotective treatments for DN over the next decade.
| Original language | English |
|---|---|
| Pages (from-to) | 820-830 |
| Number of pages | 11 |
| Journal | Trends in Endocrinology and Metabolism |
| Volume | 27 |
| Issue number | 11 |
| Early online date | 25 Jul 2016 |
| DOIs | |
| Publication status | Published - 10 Nov 2016 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Research Groups and Themes
- Bristol BioDesign Institute
Keywords
- diabetes
- synthetic biology
- SGLT2
- oxidative stress
- glomerulus
- endothelium
- podocytes
Fingerprint
Dive into the research topics of 'Diabetic Nephropathy: Perspective on Novel Molecular Mechanisms'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver